Literature DB >> 28208060

RNA toxicity and foci formation in microsatellite expansion diseases.

Nan Zhang1, Tetsuo Ashizawa2.   

Abstract

More than 30 incurable neurological and neuromuscular diseases are caused by simple microsatellite expansions consisted of 3-6 nucleotides. These repeats can occur in non-coding regions and often result in a dominantly inherited disease phenotype that is characteristic of a toxic RNA gain-of-function. The expanded RNA adopts unusual secondary structures, sequesters various RNA binding proteins to form insoluble nuclear foci, and causes cellular defects at a multisystem level. Nuclear foci are dynamic in size, shape and colocalization of RNA binding proteins in different expansion diseases and tissue types. This review sets to provide new insights into the disease mechanisms of RNA toxicity and foci modulation, in light of recent advancement on bi-directional transcription, antisense RNA, repeat-associated non-ATG translation and beyond.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28208060      PMCID: PMC5447490          DOI: 10.1016/j.gde.2017.01.005

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  152 in total

1.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

2.  Characteristic RNA foci of the abnormal hexanucleotide GGCCUG repeat expansion in spinocerebellar ataxia type 36 (Asidan).

Authors:  W Liu; Y Ikeda; N Hishikawa; T Yamashita; K Deguchi; K Abe
Journal:  Eur J Neurol       Date:  2014-07-02       Impact factor: 6.089

Review 3.  A census of human RNA-binding proteins.

Authors:  Stefanie Gerstberger; Markus Hafner; Thomas Tuschl
Journal:  Nat Rev Genet       Date:  2014-11-04       Impact factor: 53.242

4.  Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.

Authors:  Sharan Paul; Warunee Dansithong; Sonali P Jog; Ian Holt; Saloni Mittal; J David Brook; Glenn E Morris; Lucio Comai; Sita Reddy
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

5.  Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.

Authors:  Dobrila D Rudnicki; Susan E Holmes; Mark W Lin; Charles A Thornton; Christopher A Ross; Russell L Margolis
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

6.  The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila.

Authors:  Janina S Karres; Valérie Hilgers; Ines Carrera; Jessica Treisman; Stephen M Cohen
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

7.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

8.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

9.  'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization.

Authors:  María García-Murias; Beatriz Quintáns; Manuel Arias; Ana I Seixas; Pilar Cacheiro; Rosa Tarrío; Julio Pardo; María J Millán; Susana Arias-Rivas; Patricia Blanco-Arias; Dolores Dapena; Ramón Moreira; Francisco Rodríguez-Trelles; Jorge Sequeiros; Angel Carracedo; Isabel Silveira; María J Sobrido
Journal:  Brain       Date:  2012-04-03       Impact factor: 13.501

10.  Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription.

Authors:  Irene De Biase; Yogesh K Chutake; Paul M Rindler; Sanjay I Bidichandani
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more
  34 in total

1.  Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.

Authors:  Jana R Jenquin; Leslie A Coonrod; Quinn A Silverglate; Natalie A Pellitier; Melissa A Hale; Guangbin Xia; Masayuki Nakamori; J Andrew Berglund
Journal:  ACS Chem Biol       Date:  2018-08-27       Impact factor: 5.100

Review 2.  Non-coding RNAs in chromatin folding and nuclear organization.

Authors:  Sergey V Razin; Alexey A Gavrilov
Journal:  Cell Mol Life Sci       Date:  2021-06-11       Impact factor: 9.261

Review 3.  RNA-mediated toxicity in C9orf72 ALS and FTD.

Authors:  Zachary T McEachin; Janani Parameswaran; Nisha Raj; Gary J Bassell; Jie Jiang
Journal:  Neurobiol Dis       Date:  2020-08-21       Impact factor: 5.996

Review 4.  Precarious maintenance of simple DNA repeats in eukaryotes.

Authors:  Alexander J Neil; Jane C Kim; Sergei M Mirkin
Journal:  Bioessays       Date:  2017-07-13       Impact factor: 4.345

Review 5.  The potential of engineered eukaryotic RNA-binding proteins as molecular tools and therapeutics.

Authors:  Carl R Shotwell; John D Cleary; J Andrew Berglund
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-11-03       Impact factor: 9.957

Review 6.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

7.  Intron retention induced by microsatellite expansions as a disease biomarker.

Authors:  Łukasz J Sznajder; James D Thomas; Ellie M Carrell; Tammy Reid; Karen N McFarland; John D Cleary; Ruan Oliveira; Curtis A Nutter; Kirti Bhatt; Krzysztof Sobczak; Tetsuo Ashizawa; Charles A Thornton; Laura P W Ranum; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

Review 8.  An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics.

Authors:  Sanjog R Chintalaphani; Sandy S Pineda; Ira W Deveson; Kishore R Kumar
Journal:  Acta Neuropathol Commun       Date:  2021-05-25       Impact factor: 7.801

Review 9.  Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.

Authors:  Dunhui Li; Craig Stewart McIntosh; Frank Louis Mastaglia; Steve Donald Wilton; May Thandar Aung-Htut
Journal:  Transl Neurodegener       Date:  2021-05-20       Impact factor: 8.014

10.  Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 Models.

Authors:  Jana R Jenquin; Hongfen Yang; Robert W Huigens; Masayuki Nakamori; J Andrew Berglund
Journal:  ACS Pharmacol Transl Sci       Date:  2019-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.